Pliant Therapeutics Inc. (PLRX)
NASDAQ: PLRX
· Real-Time Price · USD
1.35
0.07 (5.47%)
At close: May 28, 2025, 3:59 PM
1.35
-0.37%
After-hours: May 28, 2025, 04:04 PM EDT
5.47% (1D)
| Bid | 1.22 |
| Market Cap | 83.18M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -219.51M |
| EPS (ttm) | -3.61 |
| PE Ratio (ttm) | -0.38 |
| Forward PE | -0.58 |
| Analyst | Hold |
| Ask | 1.39 |
| Volume | 959,381 |
| Avg. Volume (20D) | 1,792,045 |
| Open | 1.27 |
| Previous Close | 1.28 |
| Day's Range | 1.26 - 1.38 |
| 52-Week Range | 1.10 - 16.10 |
| Beta | 1.44 |
About PLRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PLRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PLRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-59.88%
Pilant Therapeutics shares are trading lower after...
Unlock content with
Pro Subscription
3 months ago
+20.96%
Pliant Therapeutics shares are trading higher after the company announced it initiated the assembly of an outside expert panel to review unblinded data from the ongoing BEACON-IPF Phase 2b trial of bexotegrast in patients with idiopathic pulmonary fibrosis.
